Welcome to the official website of BioCoreUSA Corp!
home > TISSUE ARRAYS > Lung > RLN04017c
  • Cores:
    96
    CASES:
    48
    Core Diameter(mm):
    1
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    12
    Tissue Array Type:
    FFPE
    Species:
    Human
RLN04017c
$290.00
Add To Collect

Description: Lung cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores

Details: Lung carcinoma tissue microarray,containing 2 cases of invasive adenocarcinoma, 11 papillary adenocarcinoma, 7 solid adenocarcinoma, 2 lepidic predominant adenocarcinoma, 26 acinar adenocarcinoma, quadruple cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • _ph
TISSUE ARRAYS
RLN04017c
1
2
3
4
5
6
7
8
9
10
11
12
A
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
B
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
C
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
D
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
E
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
F
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
G
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
H
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
_ph
RLN04017c
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 43 M Lung Acinar adenocarcinoma 1 T2aN0M0 IB Malignant
A2
2 43 M Lung Acinar adenocarcinoma 1 T2aN0M0 IB Malignant
A3
3 53 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
A4
4 53 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
A5
5 59 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
A6
6 59 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
A7
7 69 M Lung Acinar adenocarcinoma 2 T2bN2M0 IIIA Malignant
A8
8 69 M Lung Acinar adenocarcinoma 2 T2bN2M0 IIIA Malignant
A9
9 59 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
A10
10 59 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
A11
11 58 F Lung Acinar adenocarcinoma 2 T2bN1M0 IIB Malignant
A12
12 58 F Lung Acinar adenocarcinoma 2 T2bN1M0 IIB Malignant
B1
13 62 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
B2
14 62 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
B3
15 65 F Lung Acinar adenocarcinoma 2 T2bN2M0 IIIA Malignant
B4
16 65 F Lung Acinar adenocarcinoma 2 T2bN2M0 IIIA Malignant
B5
17 55 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
B6
18 55 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
B7
19 50 M Lung Acinar adenocarcinoma 2 T1aN0M0 IA Malignant
B8
20 50 M Lung Acinar adenocarcinoma 2 T1aN0M0 IA Malignant
B9
21 64 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
B10
22 64 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
B11
23 39 F Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
B12
24 39 F Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
C1
25 48 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
C2
26 48 M Lung Acinar adenocarcinoma 2 T2aN0M0 IB Malignant
C3
27 62 F Lung Acinar adenocarcinoma 2 T1aN0M0 IA Malignant
C4
28 62 F Lung Acinar adenocarcinoma 2 T1aN0M0 IA Malignant
C5
29 46 F Lung Acinar adenocarcinoma 2 T1aN0M0 IA Malignant
C6
30 46 F Lung Acinar adenocarcinoma 2 T1aN0M0 IA Malignant
C7
31 59 M Lung Acinar adenocarcinoma 2--3 T2bN0M0 IIA Malignant
C8
32 59 M Lung Acinar adenocarcinoma 2--3 T2bN0M0 IIA Malignant
C9
33 56 M Lung Acinar adenocarcinoma 2--3 T2aN1M0 IIA Malignant
C10
34 56 M Lung Acinar adenocarcinoma 2--3 T2aN1M0 IIA Malignant
C11
35 54 M Lung Acinar adenocarcinoma 3 T2aN0M0 IB Malignant
C12
36 54 M Lung Acinar adenocarcinoma 3 T2aN0M0 IB Malignant
D1
37 65 M Lung Acinar adenocarcinoma 3 T2N1M0 IIB Malignant
D2
38 65 M Lung Acinar adenocarcinoma 3 T2N1M0 IIB Malignant
D3
39 70 M Lung Acinar adenocarcinoma 3 T4N2M0 IIIB Malignant
D4
40 70 M Lung Acinar adenocarcinoma 3 T4N2M0 IIIB Malignant
D5
41 66 M Lung Acinar adenocarcinoma 3 T2bN0M0 IIA Malignant
D6
42 66 M Lung Acinar adenocarcinoma 3 T2bN0M0 IIA Malignant
D7
43 57 F Lung Acinar adenocarcinoma 3 T2aN0M0 IB Malignant
D8
44 57 F Lung Acinar adenocarcinoma 3 T2aN0M0 IB Malignant
D9
45 70 M Lung Acinar adenocarcinoma 3 T2bN0M0 IIA Malignant
D10
46 70 M Lung Acinar adenocarcinoma 3 T2bN0M0 IIA Malignant
D11
47 48 M Lung Acinar adenocarcinoma 3 T2aN0M0 IB Malignant
D12
48 48 M Lung Acinar adenocarcinoma 3 T2aN0M0 IB Malignant
E1
49 58 F Lung Acinar adenocarcinoma 3 T2aN0M0 IB Malignant
E2
50 58 F Lung Acinar adenocarcinoma 3 T2aN0M0 IB Malignant
E3
51 65 M Lung Acinar adenocarcinoma 3 T2aN2M0 IIIA Malignant
E4
52 65 M Lung Acinar adenocarcinoma 3 T2aN2M0 IIIA Malignant
E5
53 54 M Lung Papillary adenocarcinoma 2 T3N1M0 IIIA Malignant
E6
54 54 M Lung Papillary adenocarcinoma 2 T3N1M0 IIIA Malignant
E7
55 41 M Lung Papillary adenocarcinoma 2 T2aN0M0 IB Malignant
E8
56 41 M Lung Papillary adenocarcinoma 2 T2aN0M0 IB Malignant
E9
57 52 F Lung Papillary adenocarcinoma 2 T3N1M0 IIIA Malignant
E10
58 52 F Lung Papillary adenocarcinoma 2 T3N1M0 IIIA Malignant
E11
59 65 M Lung Papillary adenocarcinoma 2 T2aN0M0 IB Malignant
E12
60 65 M Lung Papillary adenocarcinoma 2 T2aN0M0 IB Malignant
F1
61 58 M Lung Papillary adenocarcinoma 2 T2bN0M0 IIA Malignant
F2
62 58 M Lung Papillary adenocarcinoma 2 T2bN0M0 IIA Malignant
F3
63 57 M Lung Papillary adenocarcinoma 2 T2bN0M0 IIA Malignant
F4
64 57 M Lung Papillary adenocarcinoma 2 T2bN0M0 IIA Malignant
F5
65 61 F Lung Papillary adenocarcinoma 2 T2aN1M0 IIA Malignant
F6
66 61 F Lung Papillary adenocarcinoma 2 T2aN1M0 IIA Malignant
F7
67 52 F Lung Papillary adenocarcinoma 2 T2aN0M0 IB Malignant
F8
68 52 F Lung Papillary adenocarcinoma 2 T2aN0M0 IB Malignant
F9
69 50 M Lung Papillary adenocarcinoma 2 T3N1M0 IIIA Malignant
F10
70 50 M Lung Papillary adenocarcinoma 2 T3N1M0 IIIA Malignant
F11
71 52 M Lung Papillary adenocarcinoma 2 T2bN0M0 IIA Malignant
F12
72 52 M Lung Papillary adenocarcinoma 2 T2bN0M0 IIA Malignant
G1
73 70 M Lung Papillary adenocarcinoma 3 T3N1M0 IIIA Malignant
G2
74 70 M Lung Papillary adenocarcinoma 3 T3N1M0 IIIA Malignant
G3
75 62 M Lung Solid adenocarcinoma 3 T2aN0M0 IB Malignant
G4
76 62 M Lung Solid adenocarcinoma 3 T2aN0M0 IB Malignant
G5
77 45 F Lung Solid adenocarcinoma 3 T2aN0M0 IB Malignant
G6
78 45 F Lung Solid adenocarcinoma 3 T2aN0M0 IB Malignant
G7
79 69 M Lung Solid adenocarcinoma 3 T3N1M0 IIIA Malignant
G8
80 69 M Lung Solid adenocarcinoma 3 T3N1M0 IIIA Malignant
G9
81 43 M Lung Solid adenocarcinoma 3 T2aN0M0 IB Malignant
G10
82 43 M Lung Solid adenocarcinoma 3 T2aN0M0 IB Malignant
G11
83 52 M Lung Solid adenocarcinoma 3 T2aN0M0 IB Malignant
G12
84 52 M Lung Solid adenocarcinoma 3 T2aN0M0 IB Malignant
H1
85 70 M Lung Solid adenocarcinoma 3 T2bN0M0 IIA Malignant
H2
86 70 M Lung Solid adenocarcinoma 3 T2bN0M0 IIA Malignant
H3
87 51 M Lung Solid adenocarcinoma 3 T2aN0M0 IB Malignant
H4
88 51 M Lung Solid adenocarcinoma 3 T2aN0M0 IB Malignant
H5
89 62 M Lung Lepidic predominant adenocarcinoma 2 T2aN0M0 IB Malignant
H6
90 62 M Lung Lepidic predominant adenocarcinoma 2 T2aN0M0 IB Malignant
H7
91 44 F Lung Lepidic predominant adenocarcinoma 2 T2aN0M0 IB Malignant
H8
92 44 F Lung Lepidic predominant adenocarcinoma 2 T2aN0M0 IB Malignant
H9
93 62 M Lung Invasive adenocarcinoma - T2aN0M0 IB Malignant
H10
94 62 M Lung Invasive adenocarcinoma - T2aN0M0 IB Malignant
H11
95 56 F Lung Invasive mucinous adenocarcinoma 2--3 T2bN1M0 IIB Malignant
H12
96 56 F Lung Invasive mucinous adenocarcinoma 2--3 T2bN1M0 IIB Malignant
_pheochromocytoma_
Find overlapping cases with this tissue array:
  • RLN04017c
    File Format: .xlsx
    Release Date: 2025-01-17 16:09:36
    Download
1.412045s